129 related articles for article (PubMed ID: 10800086)
1. Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients.
Stallwood Y; Fisher KD; Gallimore PH; Mautner V
Gene Ther; 2000 Apr; 7(8):637-43. PubMed ID: 10800086
[TBL] [Abstract][Full Text] [Related]
2. Impaired humoral responses to subgenus D adenovirusenovirus infections in HIV-positive patients.
Lord A; Bailey AS; Klapper PE; Snowden N; Khoo SH
J Med Virol; 2000 Dec; 62(4):405-9. PubMed ID: 11074466
[TBL] [Abstract][Full Text] [Related]
3. Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy.
Moffatt S; Hays J; HogenEsch H; Mittal SK
Virology; 2000 Jun; 272(1):159-67. PubMed ID: 10873758
[TBL] [Abstract][Full Text] [Related]
4. [Laboratory procedures in adenoviruses. VIII. Immunoglobulin class-specific ELISA for the demonstration of antibodies against adenovirus hexon].
Kornadt CU; Wigand R; Adrian T; Roggendorf M
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Dec; 253(3):285-96. PubMed ID: 6303017
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccines.
Pilankatta R; Chawla T; Khanna N; Swaminathan S
J Med Virol; 2010 Mar; 82(3):407-14. PubMed ID: 20087930
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of adenovirus-mediated gene transfer by bronchoalveolar lavage fluid.
Bastian A; Bewig B
Gene Ther; 1999 Apr; 6(4):637-42. PubMed ID: 10476223
[TBL] [Abstract][Full Text] [Related]
7. [Estimation of IgG Adenovirus antibody titers using a standard curve and an indirect ultramicroELISA essay].
Laferté J; Savón C; Goyenechea A; Vázquez V; Otero A; Tejero Y; Hernández B
Rev Cubana Med Trop; 1996; 48(2):102-8. PubMed ID: 9768279
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines.
Appaiahgari MB; Pandey RM; Vrati S
Clin Vaccine Immunol; 2007 Aug; 14(8):1053-5. PubMed ID: 17596429
[TBL] [Abstract][Full Text] [Related]
9. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. II. Tissue specificity and reactivity.
Kutteh WH; Doellgast GJ
J Natl Cancer Inst; 1986 May; 76(5):797-804. PubMed ID: 3517453
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
11. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients.
Heemskerk B; Lankester AC; van Vreeswijk T; Beersma MF; Claas EC; Veltrop-Duits LA; Kroes AC; Vossen JM; Schilham MW; van Tol MJ
J Infect Dis; 2005 Feb; 191(4):520-30. PubMed ID: 15655775
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation.
Niedrig M; Sonnenberg K; Steinhagen K; Paweska JT
J Virol Methods; 2007 Jan; 139(1):103-5. PubMed ID: 17084464
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic gangliosides in human ovarian carcinoma.
Ravindranath MH; Muthugounder S; Presser N; Selvan SR; Santin AD; Bellone S; Saravanan TS; Morton DL
Biochem Biophys Res Commun; 2007 Feb; 353(2):251-8. PubMed ID: 17188646
[TBL] [Abstract][Full Text] [Related]
14. Detection of false positives by incorporation of a confirmatory blocking test into a commercial enzyme-linked immunosorbent assay specific for adenovirus antigen.
Kirnpal-Kaur BS; Yap KL; Tan SC
Malays J Pathol; 1997 Dec; 19(2):133-6. PubMed ID: 10879254
[TBL] [Abstract][Full Text] [Related]
15. [Development and use of radio- and enzyme immunoassays in microbiological and immunological diagnosis. III. Comparative studies on viral antibody determination with hemagglutination, radio- and enzyme immunoassays].
Lauf H; Struy H; Morenz J
Z Gesamte Hyg; 1982 Jun; 28(6):378-81. PubMed ID: 6289540
[No Abstract] [Full Text] [Related]
16. A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial.
Alvarez RD; Barnes MN; Gomez-Navarro J; Wang M; Strong TV; Arafat W; Arani RB; Johnson MR; Roberts BL; Siegal GP; Curiel DT
Clin Cancer Res; 2000 Aug; 6(8):3081-7. PubMed ID: 10955787
[TBL] [Abstract][Full Text] [Related]
17. A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer.
Buller RE; Runnebaum IB; Karlan BY; Horowitz JA; Shahin M; Buekers T; Petrauskas S; Kreienberg R; Slamon D; Pegram M
Cancer Gene Ther; 2002 Jul; 9(7):553-66. PubMed ID: 12082455
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA.
Jansen van Vuren P; Potgieter AC; Paweska JT; van Dijk AA
J Virol Methods; 2007 Mar; 140(1-2):106-14. PubMed ID: 17174410
[TBL] [Abstract][Full Text] [Related]
19. Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies.
Jaspan HB; Robinson JE; Amedee AM; Van Dyke RB; Garry RF
J Clin Virol; 2004 Nov; 31(3):190-7. PubMed ID: 15465411
[TBL] [Abstract][Full Text] [Related]
20. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
Rao GS; Hanjani P
Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
